Indianapolis News and HeadlinesState News

Actions

Indiana to get $12.5 million in multi-state opioid settlement

Indiana Statehouse.jpg
Posted at 1:06 PM, Feb 04, 2021
and last updated 2021-02-04 13:07:03-05

INDIANAPOLIS — Indiana received a $12.5 million settlement as part of a $573 million multi-state settlement with McKinsey & Company, resolving investigations into its role in the drug epidemic.

Indiana Attorney General Todd Rokita announced the money will be used to fund prevention, education, and treatment efforts in the state.

The agreement calls for McKinsey & Company to stop advising companies on dangerous Schedule II and III narcotics, like hydrocodone, oxycodone, fentanyl, and ketamine. The agreement also calls for them to disclose internal documents about its work with Purdue Pharma and other companies to increase public transparency.

“The opioid epidemic has devastated communities in Indiana and across the nation, claiming far too many lives,” Rokita said in a press release. “We owe it to Hoosier families to hold those responsible for this crisis accountable and deliver the justice they deserve. I want to thank the attorneys in my office who have worked tirelessly to reach this historic settlement, which will bring substantial and immediate relief to communities across the state.”

The multi-state settlement announced on Thursday is the first multi-state opioid settlement resulting in a "substantial payment" to states, according to the release. Indiana and 46 other states, the District of Columbia, and five U.S. territories were apart of the settlement.

“From the first day of my administration, I made combatting the drug epidemic a top priority, and that includes holding accountable those who created and fueled this crisis," Gov. Eric Holcomb said in a statement. "I want to thank the Attorney General and his office for their work on this settlement that will help fund prevention, education and treatment efforts. No amount of money can undo the devastating toll inflicted by the opioid epidemic, but this is another step toward helping Hoosier families recover from this national crisis.”

The filing describes how McKinsey & Company sold aggressive marketing schemes and consulting services to manufacturers, that encouraged physicians to over-prescribe OxyContin, according to the release.

Resources

If you or someone you know is dealing with a substance use related emergency, call 911.

For more information on a recovery organization near you, you can visit the Indiana Recovery Network website.

You can call 211 for help 24/7 in Indiana.

You can call the Indiana Addiction Hotline at 1-800-622-HELP (4357).

To find where you can get Naloxone near you, click here.

To view more resources from NextLevel Recovery Indiana, click here to visit its website.

Learn More

Click here to learn more about substance use disorders.

Substance use disorder related data from the state.